In vitro assays play a pivotal role in de-risking ADC development by evaluating the functional efficacy, specificity, internalization, and cytotoxic potential of antibody-drug conjugates. At Aurigene, our in vitro bioassay platform is designed to provide rapid, reliable, and mechanism-relevant insights into how your ADC behaves in a cellular context. We offer target-based, cell-based, and mechanistic assays to help characterize the biological performance of ADCs prior to advancing into in vivo studies. Our team works closely with you to customize assay design based on your antibody, payload mechanism, and cancer indication of interest.
We support both standardized panels and custom assays, using validated protocols and well-characterized cell lines that match your ADC's target expression profile.
Cytotoxicity Assays (Cell Viability)
- Performed across target-positive and negative cell lines
- Quantification of IC₅₀ values
- Multiple platforms: MTT, CellTiter-Glo
Primary readout for potency and target-dependent killing
Target Expression Profiling
- Flow cytometry and western blotting to validate target antigen expression across panel of cell lines
Ensures optimal cell line selection for screening and comparators
Internalization Assays
- Flow cytometry using fluorescent-labeled antibodies or ADCs
- Time-course evaluation of ADC uptake
Confirms receptor-mediated internalization key to ADC mechanism
Receptor Binding Affinity Assays
- Surface Plasmon Resonance (SPR), Biolayer Interferometry (BLI), or flow-based binding assays
Evaluates impact of conjugation on antibody-target interaction
Bystander Killing Effect (if applicable)
- Co-culture assays using target-negative cells in presence of target-positive cells
Validates ability of membrane-permeable payloads to induce bystander cytotoxicity
Why choose Aurigene?
At Aurigene, we combine biological insight with rigorous execution to ensure your in vitro assay data is meaningful, reproducible, and aligned with clinical relevance. Our deep expertise in ADC biology, including a strong understanding of payload class, target biology, and resistance mechanisms helps us design assays that mirror real-world tumor behavior.
We offer:
Wide panel of validated human cancer cell lines
Expertise in working with diverse payloads (MMAE, MMAF, DXd, SN38, Exatecan, PNU, etc.)
Custom assay development tailored to your ADC mechanism
Flexible assay formats (96-well, real-time cytotoxicity)
Integrated support from conjugation through efficacy evaluation
Whether you are characterizing early leads or performing comparative potency for clinical candidates, Aurigene’s in vitro team delivers high-quality data that drives fast decisions making.
Virtual Tour
Hyderabad R and D Center
Bangalore R and D Center
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Methoxy Polyethylene Glycol (m-PEGs)
Aurigene Pharmaceutical Services is a leader in the synthesis of activated MethoxyPolyethyleneGlycol(m-PEGs), With a comprehensive product range and customized services. ...
Read More
Base mediated spirocyclization of quinazoline: one-step synthesis of spiro-isoindolinone dihydroquinazolinones
2020
A novel approach for the spiro-isoindolinone dihydroquinazolinones has been demonstrated from 2- aminobenzamide and 2-cyanomethyl benzoate in the presence of KHMDS as a base to get moderate yields. The reaction has been screened in various bases followed by solvents and a gram scale reaction has also been executed under the given conditions. Based on the controll...
Read More-
Ultrasound assisted rapid synthesis of mefenamic acid based indole derivatives under ligand free Cu-catalysis: Their pharmacological evaluation
2005
An improved and rapid synthesis of mefenamic acid based indole derivatives has been achieved via the ligand free Cu-catalyzed coupling-cyclization method under ultrasound irradiation. This simple, straightforward and inexpensive one-pot method involved the reaction of a terminal alkyne derived from mefenamic acid with 2- iodosulfanilides in the presence of CuI ...
Read More -
Formal synthesis of Cladospolide C & epi-Cladospolide C using R- (þ)-g-valerolactone as a chiral synthon
2005
The formal synthesis of Cladospolide-C and its analog is achieved by using enantiopure (R)-g evalerolactone 10. The significant points of this synthesis are the stereoselective dihydroxylation of a, bunsaturated ester 16 using Sharpless protocol, Wittig olefination of g evalerolactol 6 with triphenylphosphonium iodide salt 7, one pot selective oxidation ...
Read More -
Amberlite-15 promoted an unprecedented aza Michael rearrangement for one pot synthesis of dihydroquinazolinone compounds
2005
A new one pot multicomponent annulation strategy for the synthesis of various dihydroquinazolinone compounds has been developed using Amberlite-15 as a catalyst, giving good to moderate yields. In this reaction the substrate scope for amines and aldehydes was also investigated. The reaction has been checked on a large scale ...
Read More
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market